About 2.8% (95%CI: 1.8-4.4%) had a hepatitis B virus infection (total anti-HBc reactive), and 0.2% (95%CI: 0.1-1.0%) were positive for total anti-HCV. This evidence concerns the gene KRT88P and hepatitis B virus infection.